ACAmy M. Cizik

Amy M. Cizik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amy M. Cizik has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Amy M Cizik

    From the *Department of Orthopaedics and Sports Medicine, University of Washington Medical Center, Seattle, WA; the †Department of Hematology- Oncology, Children's Hospital and Regional Medical Center, Seattle, WA; and the ‡Department of Orthopaedics, Children's Hospital and Regional Medical Center, Seattle, WA

    1 shared publication
  • Douglas S Hawkins

    From the *Department of Orthopaedics and Sports Medicine, University of Washington Medical Center, Seattle, WA; the †Department of Hematology- Oncology, Children's Hospital and Regional Medical Center, Seattle, WA; and the ‡Department of Orthopaedics, Children's Hospital and Regional Medical Center, Seattle, WA

    1 shared publication
  • Edward F. Ellerbeck

    Department of Population Health, University of Kansas Medical Center, Kansas City, KS, USA

    1 shared publication
  • Ernest U Iii Conrad

    From the *Department of Orthopaedics and Sports Medicine, University of Washington Medical Center, Seattle, WA; the †Department of Hematology- Oncology, Children's Hospital and Regional Medical Center, Seattle, WA; and the ‡Department of Orthopaedics, Children's Hospital and Regional Medical Center, Seattle, WA

    1 shared publication
  • Ernest U. Conrad

    1 shared publication
  • Jason S. Weisstein

    University of Washington Medical Center

    1 shared publication

Latest Publications

  • Open Access

    Megaprosthesis versus Condyle-sparing Intercalary Allograft: Distal Femoral Sarcoma

    by Melissa N. Zimel, Amy M. Cizik, Timothy B. Rapp, Jason S. Weisstein, Ernest U. Conrad

    Although functionally appealing in preserving the native knee, the condyle-sparing intercalary allograft of the distal femur may be associated with a higher risk of tumor recurrence and endoprosthetic replacement for malignant distal femoral bone tumors. We therefore compared the risk of local tumor recurrence between patients in these two types of reconstruction groups. We retrospectively reviewed 85 patients (mean age, 22 years; range, 4–82 years), 38 (45%) of whom had a condyle-sparing allograft and 47 (55%) of whom had endoprostheses. The minimum followup for both groups was 2 years (mean, 7 years; range, 2–19 years). Local recurrences occurred in 11% (five of 47) of the patients having implants versus 18% (seven of 38) of the patients having allografts. Using time to local recurrence as an end point, the Kaplan-Meier survivorship of the implant group was similar to that of the condyle-sparing allograft group at 2, 5, and 10 years (93% versus 87% at 2 years, 87% versus 81% at 5 years, and 87% versus 81% at 10 years, respectively). The condyle-sparing allograft procedure offers the potential advantage of retaining the native knee in a young patient population while incurring no greater risk of local recurrence as those offered the endoprosthetic procedure. Level of Evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.


  • Survival of Tumor Megaprostheses Replacements about the Knee

    by Hannah D Morgan, Amy M Cizik, Seth S Leopold, Douglas S Hawkins, Ernest U Iii Conrad

    Limb salvage surgery is an effective procedure with a low risk of tumor recurrence. In an attempt to define the incidence of implant failure at 2, 5, and 10 years postoperatively, we retrospectively reviewed implant survival in a group (n = 105) of pediatric (< 18 years of age) and adult patients who were treated with distal femoral and/or proximal tibial implants for extremity tumors. Issues regarding the timing of failure, reason for failure, and whether pediatric patients had higher rates of failure were posed as secondary questions. The median followup was 57 months (1-235 months). Thirty-two (32/105, 31%) patients had 42 implant failures. The mean prosthesis Kaplan-Meier survivorship of the index group was 84% at 2 years, 73% at 5 years, and 59% at 10 years. Forty-seven percent of all failures occurred within 2 years postoperatively, and 69% occurred within 5 years postoperatively. Pediatric patients had a higher failure rate than adults (42% versus 24%). Aseptic loosening was the most common reason for failure (n = 18/32; 56%). The incidence of failure in tumor megaprostheses is similar to early published literature and the incidence of these failures is highest within the first 3 years. Level of Evidence: Therapeutic study, level IV. See Guidelines for Authors for a complete description of levels of evidence.


  • Women's Satisfaction with Their Mammography Experience: Results of a Qualitative Study

    by Kimberly K. Engelman, Amy M. Cizik, Edward F. Ellerbeck

    Objective: Many steps in getting a mammogram may produce a less than satisfactory experience. Dissatisfaction with mammography could lead to lower routine mammography adherence. The purpos...